Inventor · disambiguated record
Rachael Hawtin
Also filed as: HAWTIN RACHAEL · HAWTIN RACHAEL E
1 granted patent·18 pending applications·1 citations·filing 2003–2017
15Inventor score
Top patents by PatentIndex Score
19 records- 0154US2017370934A1Methods and compositions for immunomodulationNODALITY INC·Filed 2017·Application pending·0 cites
- 0253US2017370933A1Methods and compositions for immunomodulationNODALITY INC·Filed 2017·Application pending·0 cites
- 0352US9459246B2Induced intercellular communicationNODALITY INC·Filed 2013·Granted Oct 4, 2016·1 cites·38 claims
- 0450US2017184594A1Pathway characterization of cellsNODALITY INC·Filed 2016·Application pending·0 cites
- 0550US2017363633A1Methods for diagnosis, prognosis and methods of treatmentNODALITY INC·Filed 2017·Application pending·0 cites
- 0650US2014017678A1Pathway characterization of cellsNODALITY INC·Filed 2013·Application pending·0 cites
- 0749US2014255393A1Compositions and methods for autoimmune diseaseNODALITY INC·Filed 2014·Application pending·0 cites
- 0849US2017299590A1Methods and compositions for systemic lupus erythematosusNODALITY INC·Filed 2017·Application pending·0 cites
- 0948US2015118247A1Methods and compositions for immunomodulationNODALITY INC·Filed 2014·Application pending·0 cites
- 1048US2015202189A1Methods of using sns-595 for treatment of cancer subjects with reduced brca2 activitySUNESIS PHARMACEUTICALS INC·Filed 2014·Application pending·0 cites
- 1147US2017184587A1Compositions and methods for autoimmune diseaseNODALITY INC·Filed 2016·Application pending·0 cites
- 1246US2016223554A1Methods for diagnosis, prognosis and methods of treatmentNODALITY INC·Filed 2015·Application pending·0 cites
- 1345US2016245794A1Methods and compositions for systemic lupus erythematosusNODALITY INC·Filed 2015·Application pending·0 cites
- 1445US2017023573A1Methods and compositions for immunomodulationNODALITY INC·Filed 2016·Application pending·0 cites
- 1544US2017292946A1Methods for diagnosis, prognosis and methods of treatmentNODALITY INC·Filed 2016·Application pending·0 cites
- 1640US2017182015A1Methods of using sns-595 for treatment of cancer subjects with reduced brca2 activitySUNESIS PHARMACEUTICALS INC·Filed 2016·Application pending·0 cites
- 1737US2004186160A1Hexahydro-cyclohepta-pyrrole oxindole as potent kinase inhibitorsSUGEN INC·Filed 2003·Application pending·0 cites
- 1834US2012148564A1Methods of using sns-595 for treatment of cancer subjects with reduced brca2 activityHAWTIN RACHAEL E·Filed 2010·Application pending·0 cites
- 1926US2017199176A1T cell populations in diagnosis, prognosis, prediction, and monitoringNODALITY INC·Filed 2017·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Rachael Hawtin files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →